SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Business Segments Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Equities
002603
CNE1000015S0
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.73 CNY | -0.87% |
|
-2.90% | -36.15% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Manufacturing | 5.83B | 8.78B | 10.12B | 12.53B | 10.32B | |||||
Total Assets | 9.07B | 11.49B | 12.9B | 16.34B | 16.98B | |||||
Interest Expense | -71.9K | -3.85M | -33.97M | -33.8M | -38.9M | |||||
Income Tax Expense | 105M | 208M | 212M | 424M | 340M | |||||
CAPEX | -454M | -1.14B | -674M | -214M | -311M | |||||
EBT | 708M | 1.42B | 1.55B | 2.78B | 1.68B | |||||
D&A | 257M | 264M | 358M | 447M | 545M | |||||
Operating Income | 710M | 1.44B | 1.57B | 2.83B | 1.78B | |||||
Net Income | 607M | 1.22B | 1.34B | 2.36B | 1.35B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
China | - | 8.48B | 9.76B | 12.07B | 10.08B | |||||
Foreign | - | 304M | 357M | 463M | 239M |
MarketScreener is also available in this country: United States.
Switch edition